Data Transparency is important to reduce avoidable burden on and/or risk to trial subjects due to the avoidance of unwarranted trial repetition, enable data-driven decisions by healthcare professionals, regulators, price selection, and pharmaceutical companies, and finally to ensure unbiased reporting of clinical trials. Throughout this Conference, we will tackle data transparency from different angles with experts from the ;

3 Key objectives for this Conference:

• Enable a realistic assessment of what is required, and how these requirements could be met
• Share information with peers as this topic is complex and dynamic and it is hard to be up-to-date on all developments
• Establish and facilitate contacts between different players of the industry, the academic world, regulators and service providers